|
Glenn Foy, President Glenn joined the Company in July, 2003 as an executive consultant. Prior to Cardiva, Glenn was President and Chief Executive Officer of Sanarus, Inc., a company focused on the minimally invasive diagnosis and treatment of breast cancer. Prior to Sanarus, Glenn was Vice President of Marketing and Business Development for Circulation Inc., an early stage cardiovascular company acquired by Transvascular (Medtronic). Additionally, Glenn has held executive positions as Gynecare (acquired by Johnson & Johnson), Valleylab (acquired by Pfizer), Spectramed (acquired by Ohmeda), and FOxS Labs (acquired by Puritan Bennett). Glenn holds a BS in Biomedical Engineering, a BS in Biochemistry and Cell Biology, and an MBA. Glenn is the holder of approximately 7 issued or pending patents. | 